0001140361-23-012596.txt : 20230320 0001140361-23-012596.hdr.sgml : 20230320 20230320173552 ACCESSION NUMBER: 0001140361-23-012596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230317 FILED AS OF DATE: 20230320 DATE AS OF CHANGE: 20230320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Amy CENTRAL INDEX KEY: 0001887865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 23747285 MAIL ADDRESS: STREET 1: 38 OUTLOOK ROAD CITY: SWAMPSCOTT STATE: MA ZIP: 01907 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml X0407 4 2023-03-17 0001865494 IO Biotech, Inc. IOBT 0001887865 Sullivan Amy C/O IO BIOTECH, INC. OLE MAALOES VEH 3 COPENHAGEN G7 2200 DENMARK true Chief Financial Officer false Common Stock 2023-03-17 4 P 0 25000 2.3207 A 25000 D The transaction was executed in multiple trades in prices ranging from $2.18 to $2.46, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. /s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan 2023-03-20